Difficulty: Medium
Average Score: 88%
Practice
43-year-old woman with diagnosed myasthenia gravis presents with profound skeletal muscle weakness. We are unsure whether she is experiencing a cholinergic crisis or a myasthenic crisis, so we administer a usually appropriate dose of parenteral edrophonium. Assume the patient was actually experiencing a cholinergic crisis. Which of the following is the most likely response to the drug?
Correct answer
D
Rationale
The correct answer is D) Ventilatory distress or failure. In a cholinergic crisis, there is an excess of acetylcholine leading to overstimulation of cholinergic receptors, including those in the respiratory system. Edrophonium is a short-acting acetylcholinesterase inhibitor that temporarily increases acetylcholine levels, exacerbating symptoms in a cholinergic crisis. This can result in respiratory muscle weakness and lead to ventilatory distress or failure.
Option A) Hypertensive crisis from peripheral vascular constriction is incorrect as cholinergic crisis typically presents with symptoms of excessive parasympathetic stimulation such as bradycardia and hypotension, not hypertension.
Option B) Myocardial ischemia and angina from drug-induced tachycardia and coronary vasoconstriction is incorrect as cholinergic crisis does not typically cause coronary vasoconstriction.
Option C) Premature ventricular contractions from increased ventricular automaticity is incorrect as cholinergic crisis primarily affects muscarinic receptors, not cardiac automaticity leading to ventricular contractions.
Educationally, understanding the effects of cholinergic crisis and the pharmacological actions of edrophonium is crucial in managing patients with myasthenia gravis. Differentiating between a myasthenic crisis and a cholinergic crisis is essential as administering edrophonium in a cholinergic crisis can worsen symptoms, particularly respiratory distress. This case highlights the importance of careful assessment and knowledge of pharmacological interventions in neurological emergencies.
Option A) Hypertensive crisis from peripheral vascular constriction is incorrect as cholinergic crisis typically presents with symptoms of excessive parasympathetic stimulation such as bradycardia and hypotension, not hypertension.
Option B) Myocardial ischemia and angina from drug-induced tachycardia and coronary vasoconstriction is incorrect as cholinergic crisis does not typically cause coronary vasoconstriction.
Option C) Premature ventricular contractions from increased ventricular automaticity is incorrect as cholinergic crisis primarily affects muscarinic receptors, not cardiac automaticity leading to ventricular contractions.
Educationally, understanding the effects of cholinergic crisis and the pharmacological actions of edrophonium is crucial in managing patients with myasthenia gravis. Differentiating between a myasthenic crisis and a cholinergic crisis is essential as administering edrophonium in a cholinergic crisis can worsen symptoms, particularly respiratory distress. This case highlights the importance of careful assessment and knowledge of pharmacological interventions in neurological emergencies.